Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125210662 | 12521066 | 2 | F | 20160627 | 20160808 | 20160701 | 20160907 | PER | US-JNJFOC-20160627006 | JANSSEN | 58.02 | YR | A | F | Y | 135.17000 | KG | 20160907 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125210662 | 12521066 | 1 | PS | FENTANYL. | FENTANYL | 1 | Transdermal | N | 1513729P1 | 19813 | 12.5 | UG | PATCH | ||||||
| 125210662 | 12521066 | 2 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | EVERY 4-6 HOURS AS NEEDED | 0 | 50 | MG | TABLETS | |||||||
| 125210662 | 12521066 | 3 | C | APIDRA | INSULIN GLULISINE | 1 | Subcutaneous | WITH MEALS | 0 | 7 | IU | SOLUTION | TID | ||||||
| 125210662 | 12521066 | 4 | C | COREG | CARVEDILOL | 1 | Oral | 1/2 TABLET OF 25 MG | 0 | 12.5 | MG | TABLET | BID | ||||||
| 125210662 | 12521066 | 5 | C | COREG | CARVEDILOL | 1 | Oral | 1/2 TABLET OF 25 MG | 0 | 12.5 | MG | TABLET | BID | ||||||
| 125210662 | 12521066 | 6 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | TABLET | QID | |||||||
| 125210662 | 12521066 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 75 | UG | TABLET | ||||||||
| 125210662 | 12521066 | 8 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | TABLET | TID | |||||||
| 125210662 | 12521066 | 9 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | TABLET | TID | |||||||
| 125210662 | 12521066 | 10 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | TABLET | ||||||||
| 125210662 | 12521066 | 11 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
| 125210662 | 12521066 | 12 | C | BUMEX | BUMETANIDE | 1 | Unknown | 0 | 1 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125210662 | 12521066 | 1 | Pain |
| 125210662 | 12521066 | 2 | Pain |
| 125210662 | 12521066 | 3 | Diabetes mellitus |
| 125210662 | 12521066 | 4 | Hypertension |
| 125210662 | 12521066 | 5 | Arrhythmia |
| 125210662 | 12521066 | 6 | Pruritus |
| 125210662 | 12521066 | 7 | Hypothyroidism |
| 125210662 | 12521066 | 8 | Nausea |
| 125210662 | 12521066 | 9 | Gastric disorder |
| 125210662 | 12521066 | 10 | Sleep disorder |
| 125210662 | 12521066 | 11 | Depression |
| 125210662 | 12521066 | 12 | Oedema |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125210662 | 12521066 | Pain | |
| 125210662 | 12521066 | Poor quality drug administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125210662 | 12521066 | 1 | 20160627 | 0 | ||
| 125210662 | 12521066 | 2 | 2014 | 0 | ||
| 125210662 | 12521066 | 3 | 2014 | 0 | ||
| 125210662 | 12521066 | 4 | 2015 | 0 | ||
| 125210662 | 12521066 | 5 | 2015 | 0 | ||
| 125210662 | 12521066 | 6 | 201605 | 0 | ||
| 125210662 | 12521066 | 7 | 2016 | 0 | ||
| 125210662 | 12521066 | 9 | 2016 | 0 | ||
| 125210662 | 12521066 | 10 | 2015 | 0 | ||
| 125210662 | 12521066 | 11 | 20160620 | 0 |